ABCL
Price
$4.47
Change
-$0.14 (-3.04%)
Updated
Sep 12 closing price
Capitalization
1.34B
57 days until earnings call
RXRX
Price
$4.83
Change
-$0.02 (-0.41%)
Updated
Sep 12 closing price
Capitalization
2.11B
51 days until earnings call
Interact to see
Advertisement

ABCL vs RXRX

Header iconABCL vs RXRX Comparison
Open Charts ABCL vs RXRXBanner chart's image
AbCellera Biologics
Price$4.47
Change-$0.14 (-3.04%)
Volume$3.03M
Capitalization1.34B
Recursion Pharmaceuticals
Price$4.83
Change-$0.02 (-0.41%)
Volume$17.16M
Capitalization2.11B
ABCL vs RXRX Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. RXRX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (ABCL: $4.47 vs. RXRX: $4.83)
Brand notoriety: ABCL and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 56% vs. RXRX: 78%
Market capitalization -- ABCL: $1.34B vs. RXRX: $2.11B
ABCL [@Biotechnology] is valued at $1.34B. RXRX’s [@Biotechnology] market capitalization is $2.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ABCL is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • RXRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +5.92% price change this week, while RXRX (@Biotechnology) price change was +4.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.11B) has a higher market cap than ABCL($1.34B). ABCL YTD gains are higher at: 52.560 vs. RXRX (-28.550). ABCL has higher annual earnings (EBITDA): -197.92M vs. RXRX (-583.64M). ABCL has more cash in the bank: 553M vs. RXRX (525M). RXRX has less debt than ABCL: RXRX (88.1M) vs ABCL (142M). RXRX has higher revenues than ABCL: RXRX (64.5M) vs ABCL (32.9M).
ABCLRXRXABCL / RXRX
Capitalization1.34B2.11B63%
EBITDA-197.92M-583.64M34%
Gain YTD52.560-28.550-184%
P/E RatioN/AN/A-
Revenue32.9M64.5M51%
Total Cash553M525M105%
Total Debt142M88.1M161%
TECHNICAL ANALYSIS
Technical Analysis
ABCLRXRX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
71%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RWCIX13.560.04
+0.30%
Redwheel Global Emerging Equity I
BDOAX12.04-0.02
-0.17%
iShares MSCI Total Intl Idx Inv A
NRFYX11.65-0.03
-0.26%
Natixis AEW Global Focused Real Estate Y
LCBEX33.41-0.16
-0.48%
ClearBridge Dividend Strategy IS
PXSCX18.66-0.26
-1.37%
Impax Small Cap Investor